Red blood cell distribution width and atrial fibrillation.
atrial fibrillation (AF)
biomarker
inflammation
oxidative stress
predictor
red blood cell distribution width (RDW)
Journal
Biomarkers in medicine
ISSN: 1752-0371
Titre abrégé: Biomark Med
Pays: England
ID NLM: 101312535
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
entrez:
6
10
2020
pubmed:
7
10
2020
medline:
21
10
2021
Statut:
ppublish
Résumé
Atrial fibrillation (AF) is the most frequent arrhythmia encountered in clinical practice and is a major health problem associated with remarkable morbidity, mortality and has considerable healthcare costs. Red blood cell distribution width (RDW) reflects the heterogeneity of the volume and size of red blood cells. It is an easily measured and inexpensive index that has been associated with several cardiovascular disease states. Accumulating evidence suggests that RDW is a prognostic marker of AF in various clinical settings. In this article, we review the available data regarding the prognostic role of RDW in AF development and perpetuation in diverse disease states as well as its role on the prediction of adverse outcomes.
Identifiants
pubmed: 33021384
doi: 10.2217/bmm-2020-0041
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM